Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Selecting Anti-Melanoma Drug Targets

Posted on August 28th, 2017 by in Pharma R&D

Every year, hundreds of thousands of people are diagnosed with melanoma, the most deadly form of skin cancer. Although rates of melanoma have continued to rise over the last three decades Continue reading “Selecting Anti-Melanoma Drug Targets” »

Delivering the Right Therapy to the Right Patient with ADCs

Posted on August 11th, 2017 by in Pharma R&D

One of the most powerful tools in the fight against cancer has become the patient’s very own immune system. Among the many approaches that researchers are exploring is the use of antibody-drug conjugates (ADCs) Continue reading “Delivering the Right Therapy to the Right Patient with ADCs” »

Making the Promise of Immunotherapeutics into Reality

Posted on August 2nd, 2017 by in Chemistry

This is an exciting and hopeful time for cancer research, as new therapies and approaches are being explored that offer an alternative to standard chemotherapy, which can be effective but often carries a number of harsh side effects. Continue reading “Making the Promise of Immunotherapeutics into Reality” »